Saxenda 3 mg daily for weight management): Proven efficacy with 5-8% weight reduction and cardiovascular outcome benefits in the LEADER trial Dulaglutide (Trulicity 0.75-4.5 mg weekly): Convenient once-weekly dosing with demonstrated cardiovascular benefit in the REWIND trial Tirzepatide (Mounjaro for diabetes
1994;59:747S752S
Rick Scott on the SAVE Act and expiring TPS for over 100K Haitians in Florida 4 hours ago Urgent search for suspect after deadly shooting near Seattle's Space Needle Jul 27, 2026 Powerful tornado slams Wisconsin neighborhood Jul 27, 2026 Pres
Regular blood glucose monitoring helps patients with diabetes assess their glycemic status and anticipate changes in insulin requirements
Why Researchers Choose LY3437943 Early clinical research has focused on retatrutides effect on: Body weight and adiposity in metabolic studies Glucose regulation and insulin response Energy expenditure and appetite signaling pathways Because retatrutide acts on three key receptors at once (GLP-1, GIP, glucagon) , it allows scientists to study multi-pathway metabolic modulation in a single compound, instead of combining multiple agents
The dual GIP/GLP-1 mechanism of tirzepatide creates a slightly different side effect pattern
